Advanced search

Technetium-99m-labelled HL91 versus CT and biopsy for the visualisation of tumor recurrence of squamous head and neck carcinoma.

Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
VAN DE WIELE, C, JAN VERSIJPT, Rudi Dierckx, M MOERMAN, Marc Lemmerling, Yves D’Asseler, and Hubert Vermeersch. 2001. “Technetium-99m-labelled HL91 Versus CT and Biopsy for the Visualisation of Tumor Recurrence of Squamous Head and Neck Carcinoma.” Nuclear Medicine Communications 22 (3): 269–275.
APA
VAN DE WIELE, C, VERSIJPT, J., Dierckx, R., MOERMAN, M., Lemmerling, M., D’Asseler, Y., & Vermeersch, H. (2001). Technetium-99m-labelled HL91 versus CT and biopsy for the visualisation of tumor recurrence of squamous head and neck carcinoma. NUCLEAR MEDICINE COMMUNICATIONS, 22(3), 269–275.
Vancouver
1.
VAN DE WIELE C, VERSIJPT J, Dierckx R, MOERMAN M, Lemmerling M, D’Asseler Y, et al. Technetium-99m-labelled HL91 versus CT and biopsy for the visualisation of tumor recurrence of squamous head and neck carcinoma. NUCLEAR MEDICINE COMMUNICATIONS. 2001;22(3):269–75.
MLA
VAN DE WIELE, C, JAN VERSIJPT, Rudi Dierckx, et al. “Technetium-99m-labelled HL91 Versus CT and Biopsy for the Visualisation of Tumor Recurrence of Squamous Head and Neck Carcinoma.” NUCLEAR MEDICINE COMMUNICATIONS 22.3 (2001): 269–275. Print.
@article{144315,
  author       = {VAN DE WIELE, C and VERSIJPT, JAN and Dierckx, Rudi and MOERMAN, M and Lemmerling, Marc and D'Asseler, Yves and Vermeersch, Hubert},
  issn         = {0143-3636},
  journal      = {NUCLEAR MEDICINE COMMUNICATIONS},
  language     = {eng},
  number       = {3},
  pages        = {269--275},
  title        = {Technetium-99m-labelled HL91 versus CT and biopsy for the visualisation of tumor recurrence of squamous head and neck carcinoma.},
  volume       = {22},
  year         = {2001},
}

Web of Science
Times cited: